This Tiny Tech Stock Is Quietly Building a Huge Business in Air Quality
Source: Matt Badiali for Streetwise Reports  (1/5/21)
Independent financial analyst Matt Badiali discusses how mCloud's technology is making it possible for office buildings to reopen during the pandemic. More >

California Biotech Advances Two COVID-19 Products
Source: Streetwise Reports  (12/30/20)
Recent news concerning Sorrento Therapeutics' SARS-CoV-2 virus test and antibodies is discussed in a Dawson James Securities report. More >

DermTech Shares Rise 32% on Geisinger Health Support for Skin Cancer Test
Source: Streetwise Reports  (12/30/20)
Shares of DermTech Inc. climbed to a new 52-week high after the company reported it has received positive medical coverage by Geisinger Health System for its pigmented lesion assay, a non-invasive test for detecting melanoma. More >

BioTelemetry Shares Beat Higher on Royal Philips $2.8 Billion Buyout Offer
Source: Streetwise Reports  (12/18/20)
Shares of BioTelemetry Inc. rise 16.5% to a new 52-week high after Royal Philips agreed to acquire the company for US$2.8 billion, or US$72.00 per share in an all cash transaction. More >

Biotech's Potentially Disruptive Diagnostics Platform on 'Cusp of Commercialization'
Source: Streetwise Reports  (12/6/20)
Recent trial results, a timeline to the launch of Quotient's system and the reasons the debut should be successful are discussed in a Cowen report. More >

Renalytix AI Shares Climb 30% on Q1 Earnings and EUA for JV's SARS-CoV-2 IgG Antibody Test Kit
Source: Streetwise Reports  (11/25/20)
Shares of Renalytix AI Plc. traded 30% higher after the company reported Q1/21 financial results and that its joint venture with Mt. Sinai Health System was granted Emergency Use Authorization by the FDA for its SARS-CoV-2 IgG antibody test kit. More >

Biotech Involved in COVID-19, Neurodegenerative Diseases Reports Q3/20 Results
Source: Streetwise Reports  (11/12/20)
ProMIS Neurosciences formed two new joint ventures, one for developing tests for the detection, diagnosis and monitoring of Alzheimer's disease, and the second for serological assays for antibodies to the SARS-CoV-2 virus. More >

Individuals Succeed Using This Digital Therapy—Now It's Moving to Insurers
Source: Matt Badiali for Streetwise Reports  (11/10/20)
Independent financial analyst Matt Badiali profiles a digital therapeutics company that is changing diabetes treatment. More >

Inspire Medical's Shareholders Rest Comfortably on Q3 Earnings and Raised FY Outlook
Source: Streetwise Reports  (11/3/20)
Shares of Inspire Medical Systems traded 30% higher and set a new 52-week high after the company reported Q3/20 financial results that included a 72% rise in YoY revenue. More >

Exact Sciences Shares Rise 29% as Firm Announces Q3 Earnings, a Capital Raise and Two Acquisitions
Source: Streetwise Reports  (10/27/20)
Exact Sciences Corp. shares reached a new 52-week high after the maker of cancer screening test Cologuard reported Q3/20 financial results that included a greater than 86% increase in year-over-year revenue. More >

CareDx Shares Trade Up 15% After Announcing 57% YoY Increase in Q3 Revenue
Source: Streetwise Reports  (10/8/20)
CareDx shares established a new 52-week high after the company reported that preliminary revenue in Q3/20 increased 57% year-over-year to $53.0 million. More >

American Renal Associates Agrees to Private Equity Firm's $853 Million Buyout Offer
Source: Streetwise Reports  (10/2/20)
Shares of American Renal Associates traded 67% higher and set a new 52-week high after the company reported that it has entered into a definitive agreement to be acquired by a Nautic Partners LLC affiliate for $11.50 per share in cash. More >

Genetron Receives FDA Breakthrough Approval for Hepatocellular Carcinoma Detection Device
Source: Streetwise Reports  (9/30/20)
Genetron Holdings Ltd. shares traded 25% higher after the company reported it has received Breakthrough Device Designation from the FDA for its blood-based next-generation sequencing test for early hepatocellular carcinoma detection. More >

Aptorum Shares Skyrocket Upon Launching Infectious Disease Liquid Biopsy Unit
Source: Streetwise Reports  (9/29/20)
Shares of Aptorum Group Ltd. traded nearly 300% higher after the company reported it launched an infectious disease liquid biopsy start-up subsidiary. More >

Bringing Order to Information Chaos Is a Necessity in the Age of COVID-19
Source: Streetwise Reports  (8/31/20)
Leonovus, a data storage and security technology firm, positions its software to enable healthcare groups to organize massive amounts of COVID/public health data. More >

Firm's Home Health Monitoring System Provides the 'Most Comprehensive Offering in the Telehealth Space'
Source: Streetwise Reports  (8/26/20)
As the Covid pandemic accelerates the adoption of telemedicine technology, Reliq Health Technologies' recent contracts represent exponential growth. More >

Fluidigm Shares Climb 34% After FDA Authorizes Saliva-Based COVID-19 Test
Source: Streetwise Reports  (8/26/20)
Fluidigm Corp. shares reached a new 52-week high after the firm reported the FDA granted Emergency Use Authorization for saliva-based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19. More >

Canadian Biotech Advances Antibodies, Diagnostics Programs in Q2/20
Source: Streetwise Reports  (8/14/20)
One highlight is ProMIS Neurosciences' development of a SARS CoV-2 antibody test. More >

$18.5 Billion Merger Could Mean Big Gains for These Five Tiny Telemedicine Stocks
Source: Matt Badiali for Streetwise Reports  (8/10/20)
Independent financial analyst Matt Badiali examines five small companies poised to profit as digital health becomes mainstream during the coronavirus pandemic. More >

US Immunology Firm Lands Government Contract, Raises Cash
Source: Streetwise Reports  (8/5/20)
These two CytoSorbents events are discussed in a Dawson James report. More >

Tech Firm Explains Key Feature of its Contact Tracing Solution
Source: Streetwise Reports  (8/5/20)
Loop Insights' technology lacks the adoption challenges that app-based solutions face. More >

Fulgent Genetics' Shares Reach New 52-Week High After Posting 105% Increase in Q2 Revenue
Source: Streetwise Reports  (8/5/20)
Shares of Fulgent Genetics traded 22% higher after the company reported it posted a record $17.1 million in Q2/20 revenue and completed a record 180,513 billable tests in the quarter. More >

Mobile Health Tech Firm Joins with US Healthcare Group to Bring Care Platform to 50,000 Patients
Source: Streetwise Reports  (8/4/20)
Reliq Health Technologies reported it has entered into a new contract with Diversified Healthcare Partners to provide its iUGO Care platform to more than 50,000 patients in three U.S. states. More >

Coverage Initiated on 'Emerging Colossus in Diagnostics and Life Science'
Source: Streetwise Reports  (7/29/20)
Meridian Bioscience's business segments, revenue and growth as well as COVID-19's positive impact on them are reviewed in an H.C. Wainwright & Co. report. More >

Biopharma's Therapeutic Jumps to Phase 2 Testing for COVID-19 'to Shut Down the Cytokine Storm'
Source: Streetwise Reports  (7/22/20)
A development update on Sorrento Therapeutics' three coronavirus-related products is provided in a Dawson James report. More >